跳至主要内容
临床试验/EUCTR2020-004329-21-IT
EUCTR2020-004329-21-IT进行中(未招募)1 期

Reduction of progesterone elevation at trigger in poor responder Bologna’ criteria patients after controlled ovarian stimulation with long acting standard stimulation protocol compared with conventional daily protocol: a single center prospective randomized Fase IV trial - PE-PMA

OSPEDALE SAN RAFFAELE0 个研究点目标入组 110 人开始时间: 2021年5月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women undergoing IVF cycle, aged between 25 and 42 years, normal BMI (18.5-24.9 kg/m2), AMH level < 1.1 ng/ml and/or AFC < 5 follicles and/or < 3 oo-cytes retrieved in previous cycle, regular menstrual cycles, FSH on cycle day 3 < 20 IU/L, who have signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • BMI >25 or <18, PCOS, history of untreated autoimmune, endocrine or metabolic disorders, ovarian cystectomy or oophorectomy, FSH >= 20 lU/L, Kidney diseases, Malignant gynecological cancer, Hypersensitivity to investigated drugs , contraindication for pregnancy

研究者

发起方
OSPEDALE SAN RAFFAELE

相似试验